DeForge, Laura E

Safety and antitumor activity of recombinant soluble Apo2 ligand

Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation

Cell death mechanisms and regulationToxin Mechanisms and Immunotoxins

Cited by 2,213

Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis

Di Paolo, J. A., Huang, T., Balazs, M., Barbosa, J., Barck, K. H., Bravo, B. J., Carano, R. A. D., Darrow, J., Davies, D. R., DeForge, L. E., et al. (2011) · Nature Chemical Biology

Rheumatoid Arthritis Research and TherapiesNatural Compounds in Disease Treatment

Cited by 340

Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5

Adams, C., Totpal, K., Lawrence, D., Marsters, S., Pitti, R., Yee, S., Ross, S., Deforge, L., Koeppen, H., Sagolla, M., et al. (2008) · Cell Death & Differentiation

Cell death mechanisms and regulationMonoclonal and Polyclonal Antibodies Research

Cited by 148

Effects of altered FcγR binding on antibody pharmacokinetics in cynomolgus monkeys

Leabman, M. K., Meng, Y. G., Kelley, R. F., DeForge, L. E., Cowan, K. J., & Iyer, S. (2013) · mAbs

Monoclonal and Polyclonal Antibodies ResearchProtein purification and stability

Cited by 110